Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 1, 1980
Actinomycin D in the treatment of advanced breast cancerR A Grimm, H B Muss, D R White, et al.American Journal of Clinical Oncology|October 1, 1984
A phase II study of dibromodulcitol (DBD) in stage IV melanomaJ Hopkins, F Richards, D Case, et al.Cancer Treatment Reports|November 1, 1981
Pharmacokinetics of vincristine infusionD V Jackson, V S Sethi, C L Spurr, et al.American Journal of Clinical Oncology|April 1, 1985
A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancyH B Muss, F Richards, H D Homesley, et al.The Annals of Thoracic Surgery|July 1, 1994
Predictive value of blood clotting tests in cardiac surgical patientsG P Gravlee, S Arora, S W Lavender, et al.American Journal of Clinical Oncology|October 1, 1983
Vincristine by continuous infusion in refractory breast cancer: a phase II studyJ O Hopkins, D V Jackson, D R White, et al.American Journal of Clinical Oncology|June 1, 1983
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213D V Jackson, H B Wells, D R White, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology AssociationF Richards, L D Case, D R White, et al.American Journal of Clinical Oncology|February 1, 1984
Bone marrow evaluation in small cell lung cancerH B Muss, D V Jackson, F Richards, et al.Cancer|April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trialH B Muss, V Howard, F Richards, et al.Pageof 9